atorvastatin has been researched along with Diabetic Feet in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghorbani, R; Nassaji, M; Saboori Shkofte, H | 1 |
| Aukrust, P; Birkeland, KI; Gullestad, L; Johansen, OE; Jørgensen, AP; Orvik, E; Sørgård, B; Torjussen, BR; Ueland, T | 1 |
1 trial(s) available for atorvastatin and Diabetic Feet
| Article | Year |
|---|---|
Diabetic foot ulcer burden may be modified by high-dose atorvastatin: A 6-month randomized controlled pilot trial.
Topics: Aged; Ankle Brachial Index; Atorvastatin; Blood Pressure; C-Reactive Protein; Cost of Illness; Diabetic Foot; Dose-Response Relationship, Drug; Endpoint Determination; Female; Foot; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leukocyte Count; Lipids; Liver Function Tests; Male; Middle Aged; Pilot Projects; Pyrroles; Secondary Prevention; Wound Healing | 2009 |
1 other study(ies) available for atorvastatin and Diabetic Feet
| Article | Year |
|---|---|
Previous Atorvastatin Treatment and Risk of Diabetic Foot Infection in Adult Patients: A Case-control Study.
Topics: Atorvastatin; Case-Control Studies; Diabetic Foot; Dyslipidemias; Female; Humans; Immunologic Factors; Iran; Male; Middle Aged; Prevalence; Risk Factors; Staphylococcal Infections; Treatment Outcome | 2017 |